Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Clinuvel Pharmaceuticals Limited
  6. News
  7. Sector news
    CUV   AU000000CUV3

CLINUVEL PHARMACEUTICALS LIMITED

(CUV)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/18
40.48 AUD   -1.53%
10/17CLINUVEL PHARMACEUTICALS : Investor Webinar
PU
10/06CLINUVEL PHARMACEUTICALS : Operations Update Webcast II
PU
10/05Australia shares nearly flat as financials' losses offset tech, healthcare gains
RE
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Biopharmaceuticals
05:03pUS Stocks Extend Winning Streak as Factory Output Posts Surprise Drop
MT
04:45pCLOSE UPDATE : US Stocks Start Week Mostly Higher Ahead of Next Earnings Batch Even as Fac..
MT
01:34pEquities Mixed Midday Following Surprise Dip in Industrial Production
MT
01:21pMIDDAY REPORT : US Stocks Mixed Following Surprise Dip in Industrial Production; Treasury ..
MT
10:41aIonis Pharma Shares Drop 12% After Tofersen Study Misses Primary Endpoint
DJ
10:38aIONIS PHARMACEUTICALS : Partner Biogen Says Tofersen Study Failed to Meet Primary Goal; Sh..
MT
05:12aSouth Korean Stocks Slip on Slower Economy Growth in China, Highest Oil Prices in Years
MT
04:53aCHINA EVERGRANDE : Hong Kong shares close higher despite China's weak growth data
RE
04:12aBIOGEN : Tofersen Misses Primary Endpoint But Still Shows Signs of Reduced Disease Progres..
MT
10/17BIOGEN : trial of ALS drug fails main goal, but company says data are encouraging
RE
10/15BIOGEN : Stifel Adjusts Biogen's Price Target to $344 from $430, Keeps Buy Rating
MT
10/15BIOGEN : Cantor Fitzgerald Adjusts Price Target on Biogen to $327 From $427, Maintains Neu..
MT
10/15South Korean Stocks Close Higher on Chip Shares' Gains; Samsung, SK Hynix Move Markets
MT
10/15Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
10/15Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/14Biogen Inc. Announces Topline Results from Tofersen Phase 3 Study and Its Open Label Ex..
CI
10/13Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine
RE
10/13Australia's CSL reiterates manufacturing commitment with AstraZeneca COVID-19 vaccine
RE
10/13BIOGEN : Preliminary Analysis Suggests Certain Multiple Sclerosis Therapies May Reduce COV..
MT
10/13Biogen Inc. Announces New Data from its Industry-Leading Portfolio of Multiple Sclerosi..
CI
10/13BIOGEN : People Treated With MS Therapies Achieve Antibody Response to Covid-19 Vaccinatio..
DJ
10/12BIOGEN : Morgan Stanley Adjusts Biogen PT to $447 from $455, Keeps Overweight Rating
MT
10/11CSL Limited Provides Earnings Guidance for Fiscal Year 2022
CI
10/10SAMSUNG BIOLOGICS : Enzolytics Sign Deal for Anti-HIV, Anti-COVID-19 Monoclonal Antibody T..
MT
10/08BIOGEN : Jefferies Adjusts Biogen PT to $400 from $500, Keeps Buy Rating
MT
10/08BIOGEN : Barclays Adjusts Biogen's Price Target to $290 from $395, Keeps Equalweight Ratin..
MT
10/08Hong Kong shares close 0.6% higher as tech and financial stocks gain
RE
10/08LI NING : China stocks rise on strong services data, easing Sino-U.S. tensions
RE
10/07Enzolytics Inc. and Samsung Biologics Co., Ltd. Announce Development and Manufacturing ..
CI
10/06BIOGEN : RBC Trims Price Target on Biogen to $325 From $326, Maintains Sector Perform Rati..
MT
10/06ANALYST RECOMMENDATIONS : American Airlines, Biogen, Morgan Stanley, Rolls-Royce, United S..
10/06Alexion Pharmaceuticals, Inc. completed the acquisition of remaining majority stake in ..
CI
10/05BIOGEN : Wedbush Adjusts Price Target for Biogen to $297 From $314, Maintains Neutral Rati..
MT
10/04Seqirus, Part of CSL Limited Awarded U.S. Government Contract to Develop Two Pandemic I..
CI
10/04Sage Therapeutics and Biogen Announces Consistent Clinically Meaningful Data for Zurano..
CI
10/01Thermo Fisher Scientific Opens Manufacturing Site in Switzerland
DJ
09/30SIHUAN PHARMACEUTICAL : Pharma, WuXi Bio Units to Collaborate on Breast Cancer Drug Candid..
MT
09/29AstraZeneca's Alexion to Advance and Accelerate Ongoing Phase III Clinical Development ..
CI
09/29BIOGEN : RBC Cuts Price Target on Biogen to $326 From $341, Noting 'Slow Aduhelm Uptake,' ..
MT
09/29Alexion Pharmaceuticals, Inc. agreed to acquire remaining majority stake in Caelum Bios..
CI
09/28BIOGEN : Partner Eisai Launches Rolling Submission of Biologics License Application With F..
MT
09/23BIOGEN : Needham Starts Biogen at Buy With $400 Price Target
MT
09/22Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021,..
CI
09/20BIOGEN : Samsung Bioepis' Byooviz Approved by FDA
MT
09/20FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ, LUCENTIS Biosimilar (ranibizumab-nun..
CI
09/20Biogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
DJ
09/17Preview -- Barron's
DJ
09/17BIOGEN : Vumerity Receives Marketing Recommendation From European Medicines Agency
MT
09/17Biogen Inc. Receives Approval from European Medicines Agency for VUMERITY in the Europe..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on CLINUVEL PHARMACEUTICALS LIMITED